Multiple Sclerosis

Many patients worldwide use cannabis to alleviate pain and muscle spasms or cramps associated with multiple sclerosis or spinal cord damage. Indeed, most clinical trials with cannabinoid-based medicine have been focused on MS. 

Standard therapy often provides inadequate relief and can be limited by side effects of the medication used. As a consequence, patients suffering from multiple sclerosis have historically experimented with many alternative therapies, including cannabis, to improve their quality of life. 

Nowadays, there is much scientific proof that cannabis and cannabinoids have beneficial ef
fects on disease-related pain, bladder symptoms, tremor, and spasticity. Sleep also improves significantly by using cannabis, resulting in both deeper and longer sleep.

MS is one of the few medical conditions where long-term effects of cannabinoids have been studied (mainly in the form of the pharmaceutical product Sativex®). These results have shown that patients do not seem to develop a tolerance for the medicinal effects, and they do not need to increase their doses in order to get the same therapeutic result over time. 

Although the medical proof supporting cannabis use for MS is still somewhat limited, it is important to note that the same is true for most conventional MS medications.